149 related articles for article (PubMed ID: 730369)
21. Interaction between human polymorphonuclear leucocytes and Staphylococcus aureus in the presence and absence of opsonins.
Vandenbroucke-Grauls CM; Thijssen HM; Verhoef J
Immunology; 1984 Jul; 52(3):427-35. PubMed ID: 6086502
[TBL] [Abstract][Full Text] [Related]
22. Strain differences in the susceptibility and resistance of Pasteurella multocida to phagocytosis and killing by rabbit polymorphonuclear neutrophils.
Anderson LC; Rush HG; Glorioso JC
Am J Vet Res; 1984 Jun; 45(6):1193-8. PubMed ID: 6742581
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of human polymorphonuclear leukocyte oxidative metabolism by type 1 pili from Escherichia coli.
Goetz MB; Silverblatt FJ
Infect Immun; 1987 Mar; 55(3):534-40. PubMed ID: 2880806
[TBL] [Abstract][Full Text] [Related]
24. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria.
Yoshimura A; Hara Y; Kaneko T; Kato I
J Periodontal Res; 1997 Apr; 32(3):279-86. PubMed ID: 9138193
[TBL] [Abstract][Full Text] [Related]
25. Activation of polymorphonuclear leukocytes by spermatozoa.
Vogelpoel FR; Verhoef J
Arch Androl; 1985; 14(2-3):123-31. PubMed ID: 4062412
[TBL] [Abstract][Full Text] [Related]
26. Interactions of polymorphonuclear leukocytes with anaerobic bacteria.
Klempner MS
Rev Infect Dis; 1984; 6 Suppl 1():S40-4. PubMed ID: 6372036
[TBL] [Abstract][Full Text] [Related]
27. Killing of gram-negative bacteria by polymorphonuclear leukocytes: role of an O2-independent bactericidal system.
Weiss J; Victor M; Stendhal O; Elsbach P
J Clin Invest; 1982 Apr; 69(4):959-70. PubMed ID: 7042758
[TBL] [Abstract][Full Text] [Related]
28. Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination.
Gomez-Lus ML; Giménez MJ; Vázquez JA; Aguilar L; Anta L; Berrón S; Laguna B; Prieto J
Infection; 2003 Jan; 31(1):51-4. PubMed ID: 12590334
[TBL] [Abstract][Full Text] [Related]
29. Functional activity of enucleated human polymorphonuclear leukocytes.
Roos D; Voetman AA; Meerhof LJ
J Cell Biol; 1983 Aug; 97(2):368-77. PubMed ID: 6309859
[TBL] [Abstract][Full Text] [Related]
30. The interaction of opsonins with human polymorphonuclear leucocytes (PMN). I. The influence of human complement (C) and IgG on ingestion and digestion of C-resistant E. coli.
Berto R; Menzel J
Z Immunitatsforsch Immunobiol; 1979 Feb; 155(3):189-99. PubMed ID: 371171
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic proteins of polymorphonuclear leukocytes.
Levy O
Eur J Haematol; 1996 May; 56(5):263-77. PubMed ID: 8641399
[TBL] [Abstract][Full Text] [Related]
32. The interaction in vitro between group B meningococci and rabbit polymorphonuclear leukocytes. Demonstration of type specific opsonins and bactericidins.
Roberts RB
J Exp Med; 1967 Nov; 126(5):795-818. PubMed ID: 4964859
[TBL] [Abstract][Full Text] [Related]
33. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.
Madsen LM; Inada M; Weiss J
Infect Immun; 1996 Jul; 64(7):2425-30. PubMed ID: 8698462
[TBL] [Abstract][Full Text] [Related]
34. The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity.
Mandell GL; Rubin W; Hook EW
J Clin Invest; 1970 Jul; 49(7):1381-8. PubMed ID: 4393490
[TBL] [Abstract][Full Text] [Related]
35. Effects of Pseudomonas aeruginosa cytotoxin on human serum and granulocytes and their microbicidal, phagocytic, and chemotactic functions.
Baltch AL; Hammer MC; Smith RP; Obrig TG; Conroy JV; Bishop MB; Egy MA; Lutz F
Infect Immun; 1985 May; 48(2):498-506. PubMed ID: 3921465
[TBL] [Abstract][Full Text] [Related]
36. Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum.
Salmon D; Vilde JL; Andrieu B; Simonovic R; Lebras J
Infect Immun; 1986 Mar; 51(3):801-6. PubMed ID: 3512435
[TBL] [Abstract][Full Text] [Related]
37. Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen.
Zarember KA; Marshall-Batty KR; Cruz AR; Chu J; Fenster ME; Shoffner AR; Rogge LS; Whitney AR; Czapiga M; Song HH; Shaw PA; Nagashima K; Malech HL; DeLeo FR; Holland SM; Gallin JI; Greenberg DE
Infect Immun; 2012 Mar; 80(3):975-81. PubMed ID: 22184421
[TBL] [Abstract][Full Text] [Related]
38. Moculating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes on E. coli 0111:B4.
Tedesco F; Rottini G; Patriarca P
J Immunol; 1981 Nov; 127(5):1910-5. PubMed ID: 7028865
[TBL] [Abstract][Full Text] [Related]
39. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor.
Djeu JY; Blanchard DK
J Immunol; 1987 Oct; 139(8):2761-7. PubMed ID: 2443572
[TBL] [Abstract][Full Text] [Related]
40. Opsonin-dependent and independent surface phagocytosis of S. aureus proceeds independently of complement and complement receptors.
Gordon DL; Rice JL
Immunology; 1988 Aug; 64(4):709-14. PubMed ID: 2971611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
